Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Dearnaley

Showing results (91-100 of 185) with videos related to

Pageof 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Prognostic factors in hormone-resistant progressing cancer of the prostateS D Fosså, D P Dearnaley, M Law, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 21, 2008
Accuracy and reproducibility of conformal radiotherapy using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397)S Stanley, S Griffiths, M R Sydes, et al.
Journal of Clinical Pathology|December 1, 1981
Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusionsA To, D V Coleman, D P Dearnaley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999
Hypofractionated radiotherapy for patients with carcinoma of the bladderC C Jose, A Price, A Norman, et al.
The Journal of Urology|March 1, 1996
Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvisA Patel, P Soonawalla, S F Shepherd, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 30, 2010
The efficacy of preventing neutropenic sepsis in patients with testicular germ cell tumours: results of two consecutive auditsE M Teoh, D P Dearnaley, A Horwich, et al.
British Journal of Urology|June 1, 1994
Prognosis of testicular teratoma differentiatedM J Stevens, A R Norman, C Fisher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 24, 2019
Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate CancerM R Ferreira, K Thomas, L Truelove, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumoursJ M O'Sullivan, R A Huddart, A R Norman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Cardiovascular disease as a long-term complication of treatment for testicular cancerR A Huddart, A Norman, M Shahidi, et al.
Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1992
Prognostic factors in hormone-resistant progressing cancer of the prostateS D Fosså, D P Dearnaley, M Law, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 21, 2008
Accuracy and reproducibility of conformal radiotherapy using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397)S Stanley, S Griffiths, M R Sydes, et al.
Journal of Clinical Pathology|December 1, 1981
Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusionsA To, D V Coleman, D P Dearnaley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999
Hypofractionated radiotherapy for patients with carcinoma of the bladderC C Jose, A Price, A Norman, et al.
The Journal of Urology|March 1, 1996
Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvisA Patel, P Soonawalla, S F Shepherd, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 30, 2010
The efficacy of preventing neutropenic sepsis in patients with testicular germ cell tumours: results of two consecutive auditsE M Teoh, D P Dearnaley, A Horwich, et al.
British Journal of Urology|June 1, 1994
Prognosis of testicular teratoma differentiatedM J Stevens, A R Norman, C Fisher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 24, 2019
Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate CancerM R Ferreira, K Thomas, L Truelove, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumoursJ M O'Sullivan, R A Huddart, A R Norman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Cardiovascular disease as a long-term complication of treatment for testicular cancerR A Huddart, A Norman, M Shahidi, et al.
Pageof 19